Volume 153, Issue 1, Pages (April 2019)

Slides:

Advertisements

Similar presentations

Application of Ultrasound and Ultrasound-Guided Intervention for Evaluating Elbow Joint Pathologies Chia-Wei Lin, Yan-Hao Chen, Wen-Shiang Chen Journal.

Advertisements

Port-site recurrence in a patient undergoing robotic hysterectomy and lymph node dissection for endometrioid adenocarcinoma of the uterus Ioannis Alagkiozidis,

Volume 144, Issue 1, Pages (January 2017)

Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: A meta-analysis Zhaowei Zhu, Zhoujun Shen, Yingli Lu, Shan Zhong,

Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade.

Volume 148, Issue 1, Pages (January 2018)

Volume 148, Issue 1, Pages (January 2018)

Are patients willing to travel for better ovarian cancer care?

Volume 148, Issue 1, Pages (January 2018)

Laparoscopic nerve-sparing radical hysterectomy for bulky cervical cancer (≥6 cm) after neoadjuvant chemotherapy: A multicenter prospective cohort study

Volume 148, Issue 1, Pages (January 2018)

Volume 146, Issue 3, Pages (September 2017)

Volume 150, Issue 3, Pages (September 2018)

A. Melamed, E. J. Diver, A. A. Gockley, E. M. Hinchcliff, L

Pain in cancer survivors; filling in the gaps

Volume 151, Issue 1, Pages (October 2018)

Hysteroscopic treatment of atypical polypoid adenomyoma diagnosed incidentally in a young infertile woman Attilio Di Spiezio Sardo, M.D., Ivan Mazzon,

Volume 145, Issue 2, Pages (May 2017)

Increased body-mass index in patients with narcolepsy

Vulvar intraepithelial neoplasia: Risk factors for recurrence

Propofol compared with sevoflurane general anaesthesia is associated with decreased delayed neurocognitive recovery in older adults Y. Zhang, G.-J. Shan,

Volume 144, Issue 2, Pages (February 2017)

The efficacy of mTORC1/2 inhibition on ovarian cancer stem cells

M. Ulm, D. Lee, A.R. Mabe, M.P. Lowe, S. Kumar, T. Tillmanns

Volume 151, Issue 1, Pages (October 2018)

Wilberto Nieves-Neira, J. Julie Kim, Daniela Matei

The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non–Small Cell Lung Cancer Boris Sepesi, MD, Kathryn A. Gold, MD,

Volume 136, Issue 2, Pages (February 2015)

Supportive care plans: Linking patient-reported outcomes to evidence-based supportive care across the cancer continuum E.E. Stevens, J.N. Bottsford-Miller,

Volume 148, Issue 1, Pages (January 2018)

Volume 142, Issue 3, Pages (September 2016)

National trends in management of stage IIIC1 and IIIC2 uterine cancer: Chemotherapy and radiotherapy in isolation and sequence J. Chino, J.R. Foote,

Ni Zhang, MD, Qin-zi Xu, MD, Xiang-ning Fu, MD, Wei Sun, MD

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

Pathologic response at interval debulking surgery following neoadjuvant chemotherapy predicts improved survival in women with ovarian cancer E.N. Prendergast,

K. Bixel, N. Denlinger, L. Marsh, A. Quick, R. Salani

Volume 147, Issue 2, Pages (November 2017)

Volume 152, Issue 1, Pages (January 2019)

Volume 143, Issue 2, Pages (November 2016)

The origins of multidisciplinary cancer care

Adherence to hematologic hold parameters in dose-dense chemotherapy for ovarian malignancies: A survey of the National Comprehensive Cancer Network (NCCN)

Comparing the health and economic impacts of cervical cancer screening strategies using the Cancer Risk Management Model (CRMM) C. Popadiuk, A.J. Coldman,

I. Mert, A. R. Munkarah, R. K. Hanna, J. Chhina, M. S. Carey, M

Survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum A. Ellis, M.K. Frey, L.M. Koontz, S. Shyne,

Volume 152, Issue 1, Pages (January 2019)

Volume 150, Issue 1, Pages (July 2018)

Are ovarian cancer debulking models reliable: Variance and predictability are dependent on institutional optimal debulking rates N.A. Latif, E.M. Ko,

Volume 152, Issue 1, Pages (January 2019)

Jeffrey T. Yorio, MD, Yang Xie, PhD, Jingsheng Yan, PhD, David E

Volume 147, Issue 1, Pages (October 2017)

Cervical excisional treatment of young women: A population-based study

Volume 121, Issue 1, Pages (April 2011)

Limited access safety lead-in of the MEK inhibitor trametinib in combination with GSK , an AKT inhibitor, in patients with recurrent or persistent.

Volume 130, Issue 3, Pages (September 2013)

Jing Wu, PhD, Ning Yue, MS, Weiwei Xu, PhD

The complex interaction of cancer surgery, complications, and patient-reported outcomes: A single score is not enough K.M. Doll, E.L. Barber, J.T. Bensen,

Volume 142, Issue 2, Pages (August 2016)

Annika Idahl, Andrea Hermansson, Ann Lalos Gynecologic Oncology

Arlene Chan, Marc Buyse, Bin Yao The Lancet Oncology

Volume 130, Issue 3, Pages (September 2013)

Volume 130, Issue 1, Pages (July 2013)

In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)

Volume 147, Issue 3, Pages (December 2017)

P Combined Molecular and Radiological Evaluation Unveils Three Subtypes of Disease Progression to a Third Generation EGFR TKI Y. Zhang, Q. Zhou,

Volume 152, Issue 1, Pages (January 2019)

Tofacitinib therapy for children with severe alopecia areata

High-risk cancer, unequal care: Disparities in the complete surgical staging of high- grade endometrial cancer in the Southeastern United States J.R.

Should ovarian preservation be considered for women younger than 60 years with endometrial carcinoma? L.M. Bean, K. Taylor, K.M. Anderson, M.A. Davis,

Volume 115, Issue 1, Pages (October 2009)

Volume 154, Issue 1, Pages (July 2019)

Presentation transcript:

Volume 153, Issue 1, Pages 55-62 (April 2019) Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer Bingyi Yang, Yuhui Xu, Qin Zhu, Liying Xie, Weiwei Shan, Chengcheng Ning, Bingying Xie, Yue Shi, Xuezhen Luo, Hongwei Zhang, Xiaojun Chen Gynecologic Oncology Volume 153, Issue 1, Pages 55-62 (April 2019) DOI: 10.1016/j.ygyno.2019.01.014 Copyright © 2019 The Authors Terms and Conditions

Fig. 1 Flowchart for management of EAH and EEC patients receiving conservative treatment. *: Including general information collection, liver/renal function, expert pathology review, and imaging evaluation such as ultrasound and/or enhanced MR/CT. **: For patients remained NR after 6 months of treatment but refused hysterectomy, a multiple disciplinary discussion would be held for individual case, and alternative treatment would be given. Gynecologic Oncology 2019 153, 55-62DOI: (10.1016/j.ygyno.2019.01.014) Copyright © 2019 The Authors Terms and Conditions

Fig. 2 Flowchart of the screening of study population. Gynecologic Oncology 2019 153, 55-62DOI: (10.1016/j.ygyno.2019.01.014) Copyright © 2019 The Authors Terms and Conditions

Fig. 3 Cumulative CR rate in EAH and EEC patients. A. The cumulative complete response (CR) rate in EAH and EC patients. B. The cumulative CR rate in patients with different body mass index (BMI). Patients with BMI ≥25 kg/m2 needed longer time to achieve CR compared with those with BMI <25 kg/m2. C. The cumulative CR rate in patients with different lesion size. Patients with lesion size >2 cm needed longer time to achieve CR compared with those with lesion size ≤2 cm. Gynecologic Oncology 2019 153, 55-62DOI: (10.1016/j.ygyno.2019.01.014) Copyright © 2019 The Authors Terms and Conditions